The Duke Cancer Institute and Duke Microbiome Center are collaborating to award one development grant at the intersection of cancer and the microbiome. Proposals should include a 1-year budget of up to $50,000. All requirements for this award are identical to the DCI’s Translational and/or Collaborative Research 2022 Spring Pilot RFA with the additional requirements that (a) the PI or one of the co-PIs must also be a member of the DMC, (b) the project must support interdisciplinary and collaborative research projects in cancer and the microbiome sciences at Duke University, and (c) the research strategy document must state “DCI/DMC collaborative award” after the title (see submission guidelines in the program announcement). Note that these proposals will be considered for both traditional DCI pilot funding as well as DCI/DMC funding, but will only be eligible for one funding award. For more information, see the webpage and program announcement (note that you may need to be connected to Duke VPN to access these webpages). The deadline for proposals to this RFA is Monday, 14 March 2022.